Glutathione

Glutathione (GSH) offers a high-fidelity research tool for investigating redox buffering, hepatic detoxification, and the mitigation of oxidative stress signaling networks.

$120.00

Best Sellers

Review Third-Party Certificates of Analysis:

COA

Core Analytical Specifications:

Chemical Purity Assay

Net Mass Verification

Microbial Sterility Screening

Endotoxin (LPS) Detection

Verified
Purity
Thresholds

Independent
COA
Validation

Secure
Trackable
Shipping

Synthesized, Analytically Verified, and Dispatched from United States.

Molecular Design & Functional Mechanism

Glutathione (GSH) is a primary intracellular antioxidant central to redox buffering, detoxification pathways, and oxidative stress signaling networks.

What Research Shows 

  • Metabolic oxidative stress (6-month trial context): A randomized clinical study in people with type 2 diabetes on standard therapy reported that adding oral GSH influenced oxidative stress markers and glycemic-related measures over 6 months. 
  • Liver/metabolic health literature: A recent review summarizes GSH therapy research in fatty liver disease contexts, focusing on oxidative stress reduction and liver function markers. 

Why Research Teams Choose Glutathione

  • Direct redox control variable: Useful for testing oxidative stress causality across metabolic, hepatic, and inflammatory models.
  • Assay compatibility: Works well with ROS panels, lipid peroxidation markers, mitochondrial stress assays, and inflammatory cytokine readouts.
Molecular Design & Functional Mechanism

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. Foundation Plus supplies compounds intended for laboratory research and development purposes. Products are not promoted for consumer, medical, or veterinary use. These products are not drugs, food additives, or dietary supplements and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Related Products

Leave a review

Compliance & Age Verification

Access to the Foundation Plus digital storefront is strictly restricted to individuals 21 years of age or older.

The compounds available on this site are intended solely for laboratory research purposes. These materials are not designed to prevent, treat, or cure any medical condition and are strictly not for human consumption. By entering this site, you verify that you meet the age requirement, acknowledge these clinical restrictions, and possess a legitimate research basis for the procurement of these products.

Please note that all compounds are provided as individual units.

I am under 21 / Exit